News :: Community Pharmacist Aid

FDA approves Striverdi Respimat to treat chronic obstructive pulmonary disease

31/07/2014 19:32

FDA approves Striverdi Respimat to treat chronic obstructive pulmonary disease Today, the U.S. Food and Drug Administration approved Striverdi Respimat (olodaterol) inhalation spray to treat patients with chronic obstructive pulmonary disease (COPD), including...

FDA expands approved use of Imbruvica for chronic lymphocytic leukemia

28/07/2014 19:33

FDA expands approved use of Imbruvica for chronic lymphocytic leukemia The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion),...

FDA approves new extended-release oxycodone with abuse-deterrent properties

23/07/2014 19:30

FDA approves new extended-release oxycodone with abuse-deterrent properties Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA)...

FDA approves Zydelig for three types of blood cancers

23/07/2014 19:29

FDA approves Zydelig for three types of blood cancers The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers. Zydelig is being granted traditional approval to treat patients whose chronic...

FDA approves new product to treat rare genetic disease

17/07/2014 19:28

FDA approves new product to treat rare genetic disease The U.S. Food and Drug Administration yesterday approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary...

FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma

03/07/2014 19:26

FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma The U.S. Food and Drug Administration today approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing...

FDA approves Afrezza to treat diabetes

27/06/2014 11:50

FDA approves Afrezza to treat diabetes The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled...

FDA allows marketing of first wearable, motorized device that helps people with certain spinal cord injuries to walk

26/06/2014 11:52

FDA allows marketing of first wearable, motorized device that helps people with certain spinal cord injuries to walk The U.S. Food and Drug Administration today allowed marketing of the first motorized device intended to act as an exoskeleton for...

FDA approves Sivextro to treat skin infections

20/06/2014 11:54

FDA approves Sivextro to treat skin infections The U.S. Food and Drug Administration today approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections. Sivextro is approved to treat patients with acute bacterial skin and...

FDA approves Lymphoseek to help determine the extent of head and neck cancer in the body

13/06/2014 11:56

FDA approves Lymphoseek to help determine the extent of head and neck cancer in the body The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors...

News